Money raised by biotech: 2019 vs. 2018 Nov. 4, 2019 No Comments Total raised in public, private and other financings of biotech companies, comparing 2019 vs. 2018.Read More
From open science to a helping hand, companies, researchers collaborate Nov. 4, 2019 By Brian Orelli No Comments Companies and academic researchers have often had a dichotomous relationship, but new models are aligning the relationship.Read More
Biopharma money raised: Jan. 1 - Oct. 31, 2019 Nov. 4, 2019 No Comments Year-to-date money raised in public, private and other financings of biopharma companies.Read More
Week in review Nov. 4, 2019 No Comments Centogene BV filed to sell 4 million common shares on Nasdaq for between $14 and $16 in an IPO expected to raise $60 million at the midpoint.Read More
Word on the street Nov. 4, 2019 No Comments “We’re in a global market. We need to stop being parochial and work globally from the beginning.”Read More
Week in Washington Nov. 4, 2019 No Comments The FDA’s Janet Woodcock, director of the Center for Drug Evaluation and Research, testified before a House subcommittee on the national security risk raised by U.S. reliance on China exports of active pharmaceutical ingredients (API).Read More
Biotech money raised by month in 2019 (US$M) Nov. 4, 2019 No Comments Biotech money raised to-date and by month in 2019, including public, private and other financings. Read More
Follow-on offerings of biopharma companies in October 2019 Nov. 4, 2019 No Comments Follow-ons completed by biopharma companies in October 2019.Read More
Completed and pending biopharma IPOs in October 2019 Nov. 4, 2019 No Comments Completed and pending initial public offerings by biopharma companies in October 2019.Read More
Other financings of public biotechnology companies in October 2019 Nov. 4, 2019 No Comments Private placements and other private financings of public biopharma companies in October 2019.Read More